Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction

Background: There is ongoing debate regarding the optimal antiplatelet strategy beyond 12 months in patients with acute myocardial infarction (AMI) who undergo successful percutaneous coronary intervention (PCI). This study therefore aimed to investigate the clinical outcomes of single (SAPT) vs. du...

Descripción completa

Detalles Bibliográficos
Autores principales: Roh, Ji Woong, Bae, SungA, Kim, Yongcheol, Son, Nak-Hoon, Cho, Deok-Kyu, Kim, Jung-Sun, Kim, Byeong-Keuk, Choi, Donghoon, Hong, Myeong-Ki, Jeong, Myung Ho, Jang, Yangsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652119/
https://www.ncbi.nlm.nih.gov/pubmed/34901239
http://dx.doi.org/10.3389/fcvm.2021.783344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652119/
https://www.ncbi.nlm.nih.gov/pubmed/34901239
http://dx.doi.org/10.3389/fcvm.2021.783344

Ejemplares similares